|
|
Volumn 10, Issue 4, 2004, Pages 32-36
|
|
Antibacterial drug discovery: Is small pharma the solution?
|
|
Author keywords
Antibacterial; Biotech; Drug discovery; Large Pharma; Small pharma
|
|
Indexed keywords
9 ACETYLIMINO 3 DEHEXAPYRANOSYLOXY 9 DEOXO 3 OXO 6 O,11 O [2 [6 (1 PYRAZOLYL) 3 PYRIDINYLMETHOXYIMINO]PROPYLENE]ERYTHROMYCIN;
ADAPTIDE DERIVATIVE;
AMPHOTERICIN;
ANIDULAFUNGIN;
ANTHRAX VACCINE;
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTIINFECTIVE AGENT;
ANTIMYCOBACTERIAL AGENT;
BETA LACTAMASE INHIBITOR;
BP 102;
CARBACEPHEM DERIVATIVE;
CBR 1477;
CEFTOBIPROLE;
CEFTOBIPROLE MEDOCARIL;
CEPHALOSPORIN DERIVATIVE;
DALBAVANCIN;
DAPTOMYCIN;
DORIPENEM;
ETHAMBUTOL;
FROPENEM;
GEMIFLOXACIN;
GYRASE INHIBITOR;
ICLAPRIM;
LINCOSAMIDE DERIVATIVE;
LYSOSTAPHIN;
MACROLIDE;
MBI 226;
NATURAL PRODUCT;
ORITAVANCIN;
PEPTIDE DEFORMYLASE INHIBITOR;
POLYPEPTIDE ANTIBIOTIC AGENT;
PPI 0903;
PTK 0796;
RAMOPLANIN;
RIFALAZIL;
RIFAMYCIN;
SORDARIN DERIVATIVE;
TETRACYCLINE DERIVATIVE;
UNCLASSIFIED DRUG;
ANTIBIOTIC RESISTANCE;
ARTICLE;
CLINICAL TRIAL;
DRUG CLASSIFICATION;
DRUG COST;
DRUG DESIGN;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SYNTHESIS;
HOSPITAL INFECTION;
HUMAN;
PATENT;
PRIORITY JOURNAL;
PUBLIC HEALTH SERVICE;
RESPIRATORY TRACT INFECTION;
DRUG LEGISLATION;
ECONOMICS;
METHODOLOGY;
PHARMACEUTICS;
ANTI-BACTERIAL AGENTS;
DRUG DESIGN;
DRUG INDUSTRY;
HUMANS;
TECHNOLOGY, PHARMACEUTICAL;
|
|
EID: 16644389450
PISSN: 14709465
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1465-0691.2004.1008.x Document Type: Article |
|
Times cited : (19)
|
|
References (0)
|
